Cepher公司成立于1996年，是一个开发生产用于生命科学研究和传染性疾病诊断一起的厂家。Cepheid上市代码CPHD，总部在美国加州桑尼维尔，是一家分子诊断公司，致力于开发、生产、商品化用于临床、工业、防生物武器的基因分析全整合系统。公司的快速复杂系统可以替代原有的复杂的实验室手工操作，自动化检测生命体和基因疾病。易用的系统整合了一系列复杂和耗时的步骤，包括样品制备、DNA扩增及检测，这样就可以在公司专有的监测盒中分析复杂的生物样品。拥有强大的分子生物学能力，公司致力于发展可以用于需要快速分子检测的方法，如在临床中的发现传染性疾病和肿瘤，工业市场中的食品、农业、环境测试，反生物恐怖中的发现生物恐怖病源体。

 Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the Company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market.